GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome - Top-Institutions - MDSpire

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome

  • By

  • Laetitia Largeaud

  • Vincent Fregona

  • Laura A. Jamrog

  • Camille Hamelle

  • Stéphanie Dufrechou

  • Naïs Prade

  • Esmaa Sellam

  • Pauline Enfedaque

  • Manon Bayet

  • Sylvie Hébrard

  • Mathieu Bouttier

  • Christine Didier

  • Bastien Gerby

  • Eric Delabesse

  • Marlène Pasquet

  • Cyril Broccardo

  • January 30, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Stem Cell Institute
    Harvard Stem Cell Institute

    Cambridge, MA

    Key Differentiators

    • Hematology
    • Stem Cell Biology
    • Genetics

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Genomics

  • #3

    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)
    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Genetics
    • Stem Cell Research

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Genetics

  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Biology
    • Genetics

Original Source(s)

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome

  • by Laetitia Largeaud, Vincent Fregona, Laura A. Jamrog, Camille Hamelle, Stéphanie Dufrechou, Naïs Prade, Esmaa Sellam, Pauline Enfedaque, Manon Bayet, Sylvie Hébrard, Mathieu Bouttier, Christine Didier, Bastien Gerby, Eric Delabesse, Marlène Pasquet, Cyril Broccardo

  • January 30, 2025

Related Content

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • by

  • February 13, 2026

  • 12 min
The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee

  • November 5, 2025

Correction: TET2 deficiency promotes MDS-associated leukemogenesis